Loading...
The science of fuel switching — and how MOTS-c, 5-Amino-1MQ, and GLP-1 agonists restore it
A healthy metabolism is not about burning a lot of calories — it's about burning the RIGHT fuel at the RIGHT time. After a meal, your body should efficiently store glucose as glycogen and switch to fat burning between meals. During exercise, it should ramp up both glucose and fat oxidation based on intensity. During sleep, it should rely almost entirely on fat as fuel.
This ability to smoothly transition between fuel sources is called metabolic flexibility. When it works, you have stable energy throughout the day, easy body composition management, and efficient recovery. When it breaks down — which happens with aging, chronic inflammation, and insulin resistance — you get locked into glucose dependency.
Metabolic inflexibility means your body can't efficiently access fat stores for fuel. The result: constant hunger, energy crashes between meals, stubborn visceral fat, and a metabolism that fights against fat loss regardless of calorie restriction.
Metabolic flexibility doesn't just disappear — it's degraded by the same three root causes that drive most metabolic dysfunction:
The Three Root Causes of Metabolic Inflexibility
This is why metabolic flexibility is the unifying concept in the DoseCraft framework. It's not a fourth root cause — it's the downstream result of all three root causes acting together. Fix the root causes, and metabolic flexibility returns.
Each compound in this approach targets a different barrier to metabolic flexibility. Used together, they create a synergistic effect where removing one barrier amplifies the impact of removing the others.
AMPK is the master energy sensor that triggers the switch from glucose to fat burning. It's activated by exercise, fasting, and caloric deficit — all situations where cells need to access stored energy. MOTS-c directly activates AMPK, mimicking the metabolic state of exercise without the physical demand.
Dose
5mg, three times per week
Frequency
Mon / Wed / Fri
Route
Subcutaneous injection
Mechanism: Activates AMPK to restore the glucose-to-fat fuel switching mechanism. Enhances fat oxidation and glucose uptake simultaneously, improving overall metabolic flexibility.
NAD+ is a cofactor required by virtually every metabolic enzyme in your body. It's essential for beta-oxidation (fat burning), the citric acid cycle, and the electron transport chain. The enzyme NNMT (nicotinamide N-methyltransferase) depletes NAD+ by methylating it into an inactive form. 5-Amino-1MQ inhibits NNMT, preserving the NAD+ pool that metabolic flexibility depends on.
Dose
50mg daily
Frequency
Once daily, morning
Route
Oral capsule
Mechanism: NNMT inhibitor that preserves NAD+ levels. Supports the metabolic enzyme function required for efficient fuel switching and fat oxidation. Also reduces visceral fat accumulation directly.
Insulin resistance is the single biggest barrier to metabolic flexibility. When insulin is chronically elevated, your body cannot access fat stores — no matter how much you restrict calories or exercise. GLP-1 agonists like Semaglutide improve insulin sensitivity through multiple mechanisms: enhanced insulin secretion, reduced glucagon, slowed gastric emptying, and direct effects on pancreatic beta cells.
Dose
0.25mg — 2.4mg weekly (titrated)
Frequency
Once weekly
Route
Subcutaneous injection
Mechanism: GLP-1 receptor agonist that improves insulin sensitivity, reduces glucagon, and breaks the insulin resistance cycle. By lowering baseline insulin levels, it unlocks access to fat stores — the prerequisite for metabolic flexibility.
| Step 1: Unlock fat stores | Semaglutide reduces insulin resistance → fat becomes accessible as fuel |
| Step 2: Activate the switch | MOTS-c activates AMPK → cells start preferring fat oxidation |
| Step 3: Power the machinery | 5-Amino-1MQ preserves NAD+ → metabolic enzymes for fat burning function optimally |
| Net result | Stable energy, reduced cravings, progressive fat loss, improved exercise tolerance, better recovery |
Log doses, monitor interactions, and optimize your stack with AI tools.
Open DoseCraftPharma-grade, third-party tested. Our preferred vendor for the DoseCraft community.
Shop Peptide PartnersTrack these markers in DoseCraft:
Metabolic flexibility isn't a niche biohacking concept — it's the foundation of metabolic health. Every major chronic disease (type 2 diabetes, cardiovascular disease, neurodegenerative disease, cancer) involves some degree of metabolic inflexibility. By restoring your body's ability to efficiently switch between fuel sources, you're not just losing fat or gaining energy — you're addressing the metabolic root of aging itself.
The peptide approach works because it targets the barriers from multiple angles simultaneously. Calorie restriction alone can't fix mitochondrial decline. Exercise alone can't overcome severe insulin resistance. But combining targeted compounds that address each barrier — while maintaining proper nutrition and movement — creates the metabolic environment where flexibility naturally returns.
This article is for educational purposes only. Semaglutide is FDA-approved for specific indications — consult your physician. MOTS-c and 5-Amino-1MQ are research compounds. Always work with a licensed healthcare professional before starting any protocol.
Track your protocol with precision tools. Source pharma-grade compounds from a trusted vendor.
Build this protocol in 60 seconds. AI-powered dose logging, half-life tracking, and interaction checks.
Open Protocol BuilderPharma-grade, third-party tested peptides from our preferred vendor. Trusted by the community.
Shop Peptide PartnersMenopause triggers metabolic dysfunction through three root causes: inflammation, insulin resistance, and mitochondrial decline. This protocol targets all three simultaneously using four evidence-backed compounds.
Read researchSemaglutide is FDA-approved for weight loss, but body recomposition — losing fat while preserving muscle — requires a different approach. This article covers GLP-1 mechanisms, muscle-sparing strategies, resistance training protocols, and the tirzepatide comparison for recomp goals.
Read researchLeading clinical practitioners identify three root causes underlying virtually all chronic disease: systemic inflammation, insulin resistance, and ATP (energy) failure. Understanding this framework transforms how you approach health optimization with peptides.
Read researchNot medical advice — educational only. DoseCraft is an information and personal tracking platform. We do not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting any protocol. Affiliate links may be present — we only recommend vendors we trust.